SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

CAMPO, Gianluca Calogero
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 32.605
AS - Asia 21.164
EU - Europa 14.639
SA - Sud America 3.576
AF - Africa 500
OC - Oceania 73
Continente sconosciuto - Info sul continente non disponibili 15
AN - Antartide 1
Totale 72.573
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 31.640
SG - Singapore 8.135
FI - Finlandia 4.767
CN - Cina 4.424
IT - Italia 2.904
BR - Brasile 2.784
VN - Vietnam 2.320
DE - Germania 1.982
HK - Hong Kong 1.691
BD - Bangladesh 1.271
GB - Regno Unito 961
FR - Francia 764
UA - Ucraina 731
TR - Turchia 645
JP - Giappone 626
IN - India 530
PL - Polonia 498
CA - Canada 459
RU - Federazione Russa 452
ID - Indonesia 407
SE - Svezia 377
MX - Messico 362
NL - Olanda 288
AR - Argentina 268
ZA - Sudafrica 188
IQ - Iraq 182
ES - Italia 180
CO - Colombia 134
PK - Pakistan 131
AT - Austria 130
EC - Ecuador 127
BE - Belgio 99
LT - Lituania 78
UZ - Uzbekistan 78
VE - Venezuela 77
SA - Arabia Saudita 76
PH - Filippine 74
MY - Malesia 68
KR - Corea 67
AU - Australia 66
IE - Irlanda 61
CH - Svizzera 58
MA - Marocco 58
CZ - Repubblica Ceca 53
CL - Cile 50
AE - Emirati Arabi Uniti 48
EG - Egitto 48
PY - Paraguay 44
TN - Tunisia 43
JO - Giordania 41
KE - Kenya 40
PE - Perù 38
NP - Nepal 37
IR - Iran 33
AL - Albania 32
UY - Uruguay 32
JM - Giamaica 30
TH - Thailandia 30
DZ - Algeria 26
LB - Libano 24
KZ - Kazakistan 23
PT - Portogallo 23
IL - Israele 21
TW - Taiwan 21
AZ - Azerbaigian 20
DK - Danimarca 20
DO - Repubblica Dominicana 20
KG - Kirghizistan 20
OM - Oman 19
SN - Senegal 19
ET - Etiopia 18
HR - Croazia 18
RO - Romania 17
PS - Palestinian Territory 16
CR - Costa Rica 15
RS - Serbia 15
MD - Moldavia 14
PA - Panama 14
BG - Bulgaria 13
CY - Cipro 13
NI - Nicaragua 13
SI - Slovenia 13
HN - Honduras 12
HU - Ungheria 12
GE - Georgia 11
BO - Bolivia 10
BH - Bahrain 9
GR - Grecia 9
LV - Lettonia 9
SK - Slovacchia (Repubblica Slovacca) 9
SY - Repubblica araba siriana 9
CI - Costa d'Avorio 8
GT - Guatemala 8
NO - Norvegia 8
SV - El Salvador 8
TT - Trinidad e Tobago 8
XK - ???statistics.table.value.countryCode.XK??? 8
BY - Bielorussia 7
GY - Guiana 7
KW - Kuwait 7
Totale 72.411
Salva come PNG Salva come JPEG
Città #
Singapore 4.919
Ashburn 4.648
Helsinki 4.366
San Jose 2.696
Fairfield 2.306
Woodbridge 1.819
Hong Kong 1.648
Santa Clara 1.484
Dallas 1.373
Beijing 1.368
Houston 1.245
Chandler 1.035
Munich 1.029
Seattle 987
New York 908
Wilmington 853
Ann Arbor 810
Jacksonville 770
Cambridge 767
Ho Chi Minh City 763
Los Angeles 749
Tokyo 591
Hanoi 518
Warsaw 468
Council Bluffs 423
Lauterbourg 413
Ferrara 381
Izmir 344
Princeton 326
Milan 317
São Paulo 311
Jakarta 296
Shanghai 285
Nanjing 272
San Diego 216
Orem 211
London 210
Mexico City 209
Buffalo 207
Chicago 205
Turku 187
Bologna 172
Rome 164
Frankfurt am Main 158
Boardman 146
Montreal 146
Toronto 132
Chennai 131
Atlanta 129
Brooklyn 129
Denver 126
Hefei 121
Nuremberg 115
Phoenix 114
Rio de Janeiro 109
Da Nang 104
Amsterdam 102
Haiphong 102
Boston 97
Brussels 96
Stockholm 96
Johannesburg 94
Moscow 94
San Francisco 94
Tianjin 89
Manchester 84
Poplar 81
The Dalles 81
Bremen 80
Shenyang 78
Washington 77
Mumbai 74
Falkenstein 73
Nanchang 72
Tashkent 69
Baghdad 64
Lappeenranta 64
Redwood City 64
Falls Church 63
Columbus 61
Ankara 58
Paris 56
Guangzhou 55
Jiaxing 55
Salt Lake City 55
Belo Horizonte 54
Dhaka 52
Dublin 52
Naples 51
Quito 50
Biên Hòa 48
Changsha 48
Charlotte 47
Medellín 47
Mountain View 44
Brasília 43
New Delhi 43
Shenzhen 43
Vienna 42
Hebei 40
Totale 47.861
Salva come PNG Salva come JPEG
Nome #
1,3,8-Triazaspiro[4.5]decane Derivatives Inhibit Permeability Transition Pores through a FO-ATP Synthase c Subunit Glu119-Independent Mechanism That Prevents Oligomycin A-Related Side Effects 2.863
A naturally occurring mutation in ATP synthase subunit c is associated with increased damage following hypoxia/reoxygenation in STEMI patients 2.056
Applied coronary physiology for planning and guidance of percutaneous coronary interventions. A clinical consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the European Society of Cardiology 428
A counseling program on nuisance bleeding improves quality of life in patients on dual antiplatelet therapy: A randomized controlled trial 421
Mitochondrial permeability transition involves dissociation of F1FO ATP synthase dimers and C-ring conformation 407
Physical activity intervention for elderly patients with reduced physical performance after acute coronary syndrome (HULK study): Rationale and design of a randomized clinical trial 373
Effectiveness and safety of the ABSORB bioresorbable vascular scaffold for the treatment of coronary artery disease: Systematic review and meta-analysis of randomized clinical trials 371
Biological effects of ticagrelor over clopidogrel in patients with stable coronary artery disease and chronic obstructive pulmonary disease 358
Exercise Intervention to Improve Functional Capacity in Older Adults After Acute Coronary Syndrome 343
Molecular identity of the mitochondrial permeability transition pore and its role in ischemia-reperfusion injury 338
Discovery of Novel 1,3,8-Triazaspiro[4.5]decane Derivatives That Target the c Subunit of F1/FO-Adenosine Triphosphate (ATP) Synthase for the Treatment of Reperfusion Damage in Myocardial Infarction 324
Diagnostic accuracy of baseline troponin and troponin change for the diagnosis of myocardial infarction complicated with heart failure 308
Atrial Longitudinal Strain Predicts New-Onset Atrial Fibrillation: A Systematic Review and Meta-Analysis 301
Poor response to clopidogrel: current and future options for its management 291
Evolving Routine Standards in Invasive Hemodynamic Assessment of Coronary Stenosis: The Nationwide Italian SICI-GISE Cross-Sectional ERIS Study 289
Bioresorbable Scaffold vs. Second Generation Drug Eluting Stent in Long Coronary Lesions requiring Overlap: A Propensity-Matched Comparison (the UNDERDOGS study) 280
Prospective identification of stent fracture by enhanced stent visualization system during percutaneous coronary intervention 280
Fo ATP synthase C subunit serum levels in patients with ST-segment Elevation Myocardial Infarction: Preliminary findings 279
How the functional assessment of culprit and non-culprit lesions may improve stratification and treatment of STEMI patients 272
Chronic Obstructive Pulmonary Disease and Ischemic Heart Disease Comorbidity: Overview of Mechanisms and Clinical Management 264
High-dose BoluS TiRofibAn and Sirolimus eluting STEnt versus abiciximab and bare metal stent in acute MYocardial infarction (STRATEGY) study - Protocol design and demography of the first 100 patients 262
Amino terminal pro brain natriuretic peptide predicts all-cause mortality in patients with chronic obstructive pulmonary disease: Systematic review and meta-analysis 260
Antiplatelet Treatment Reduces All-Cause Mortality in COPD Patients: A Systematic Review and Meta-Analysis 259
Bleeding Risk Scores and Scales of Frailty for the Prediction of Haemorrhagic Events in Older Adults with Acute Coronary Syndrome: Insights from the FRASER study 256
Quantitative Flow Ratio Identifies Nonculprit Coronary Lesions Requiring Revascularization in Patients with ST-Segment-Elevation Myocardial Infarction and Multivessel Disease 255
The use of nutraceuticals to counteract atherosclerosis: The role of the Notch pathway 253
1- or 3-Month DAPT in Patients With HBR With or Without Oral Anticoagulant Therapy After PCI 250
Endothelial dysfunction and increased platelet reactivity in patients with acute coronary syndrome and undiagnosed COPD: insights into the SCAP trial 250
Characterization of Dermal Stem Cells of Diabetic Patients 250
Translating Evidence from Clonal Hematopoiesis to Cardiovascular Disease: A Systematic Review 250
Factor XI rs2036914 gene polymorphism and occurrence of adverse events after percutaneous coronary intervention. A prospective evaluation. 248
Clinical benefit of drugs targeting mitochondrial function as an adjunct to reperfusion in ST-segment elevation myocardial infarction: A meta-analysis of randomized clinical trials 243
The assessment of scales of frailty and physical performance improves prediction of major adverse cardiac events in older adults with acute coronary syndrome 243
Tissue factor and coagulation factor VII levels during acute myocardial infarction: Association with genotype and adverse events 241
The Mitochondrial Permeability Transition Pore 241
The frailty in elderly patients receiving cardiac interventional procedures (FRASER) program: rational and design of a multicenter prospective study 240
Inhaled corticosteroid/long-acting bronchodilator treatment mitigates STEMI clinical presentation in COPD patients 238
Reperfusion Damage - A Story of Success, Failure, and Hope 236
Grip strength predicts cardiac adverse events in patients with cardiac disorders: An individual patient pooled meta-analysis 236
Medical and interventional management of patients with severe thrombocytopenia undergoing percutaneous coronary intervention 235
Cost-effectiveness of the coronary sinus Reducer and its impact on the healthcare burden of refractory angina patients 235
ACE inhibition modulates endothelial apoptosis and renewal via endothelial progenitor cells in patients with acute coronary syndromes 234
C subunit of F1/FO-ATP synthase as target for preventing the detrimental effect of myocardial ischemia/reperfusion injury 233
Adenosine-Free Indexes vs. Fractional Flow Reserve for Functional Assessment of Coronary Stenoses: Systematic Review and Meta-Analysis 229
Mechanistic role of mPTP in ischemia-reperfusion injury 228
SERPINA1 Gene Promoter Is Differentially Methylated in Peripheral Blood Mononuclear Cells of Pregnant Women 228
Comparison of Verapamil versus Heparin as Adjunctive Treatment for Transradial Coronary Procedures: The VERMUT Study 227
Angio-based index of microcirculatory resistance for the assessment of the coronary resistance: A proof of concept study 225
ACE inhibition modulates endothelial apoptosis and renewal via endothelial progenitor cells in patients with acute coronary syndromes (Am Journal of Cardiovasc Drugs (2011) 11:3 (189-98)) 222
Blood Interferon-α Levels and Severity, Outcomes, and Inflammatory Profiles in Hospitalized COVID-19 Patients 222
Transcatheter aortic-valve implantation with or without on-site cardiac surgery: The TRACS trial 221
Context-dependent function of ROS in the vascular endothelium: The role of the Notch pathway and shear stress 219
A serum proteome signature to predict mortality in severe COVID-19 patients 219
Cardiac troponin elevation predicts all-cause mortality in patients with acute exacerbation of chronic obstructive pulmonary disease: Systematic review and meta-analysis 218
Nutritional status and all-cause mortality in older adults with acute coronary syndrome 217
BRS implantation in long lesions requiring device overlapping: Myth or reality? 215
Can we improve myocardial protection during ischaemic injury? 215
Direct oral anticoagulants for the treatment of left ventricular thrombosis: an updated systematic review and meta-analysis 214
In Vitro Characterization of Circulating Endothelial Progenitor Cells Isolated from Patients with Acute Coronary Syndrome 214
Impact of proton pump inhibitors on clinical outcomes in patients treated with a 6- or 24-month dual-antiplatelet therapy duration: Insights from the PROlonging Dual-antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY trial 214
Diagnostic performance of in-procedure angiography-derived quantitative flow reserve compared to pressure-derived fractional flow reserve: The FAVOR II Europe-Japan study 214
Contrast Associated Acute Kidney Injury and Mortality in Older Adults with Acute Coronary Syndrome: A Pooled Analysis of the FRASER and HULK Studies 212
CHA2DS2-VASc score predicts atrial fibrillation recurrence after cardioversion: systematic review and individual patient pooled meta-analysis 209
Effectiveness of a novel nutraceutical compound containing red yeast rice, polymethoxyflavones and antioxidants in the modulation of cholesterol levels in subjects with hypercholesterolemia and low-moderate cardiovascular risk: The NIRVANA study 208
Short Physical Performance Battery and all-cause mortality: Systematic review and meta-analysis 205
Predicting return to work after acute myocardial infarction: Socio-occupational factors overcome clinical conditions 205
Randomized, double-blind comparison of effects of abiciximab bolus only vs. on-label regimen on ex vivo inhibition of platelet aggregation in responders to clopidogrel undergoing coronary stenting 204
Adding a “Notch” to Cardiovascular Disease Therapeutics: A MicroRNA-Based Approach 204
Kounis-Zavras syndrome presenting with ventricular arrhythmias and cardiogenic shock 202
Intensifying platelet inhibition with tirofiban in poor responders to aspirin, clopidogrel, or both agents undergoing elective coronary intervention: Results from the double-blind, prospective, randomized tailoring treatment with tirofiban in patients showing resistance to aspirin and/or resistance to clopidogrel study 201
Impact of COPD on Long-term Outcome After ST-Segment Elevation Myocardial Infarction Receiving Primary Percutaneous Coronary Intervention 201
Data on administration of cyclosporine, nicorandil, metoprolol on reperfusion related outcomes in ST-segment Elevation Myocardial Infarction treated with percutaneous coronary intervention 200
Fractional flow reserve: Current applications and overview of the available data 199
Ticagrelor improves endothelial function by decreasing circulating Epidermal Growth Factor (EGF) 199
Exercise intervention improves quality of life in older adults after myocardial infarction: randomised clinical trial 199
Ticagrelor Increases SIRT1 and HES1 mRNA Levels in Peripheral Blood Cells from Patients with Stable Coronary Artery Disease and Chronic Obstructive Pulmonary Disease 199
Peak atrial longitudinal strain is predictive of atrial fibrillation in patients with chronic obstructive pulmonary disease and coronary artery disease 199
Tailored Medical and Interventional Therapy Against Recurrent Stent Thrombosis After Drug-Eluting Stenting 198
Predischarge screening for chronic obstructive pulmonary disease in patients with acute coronary syndrome and smoking history 198
Meta-Analysis of the Duration of Dual Antiplatelet Therapy in Patients Treated with Second-Generation Drug-Eluting Stents 198
Notch Signaling Regulates Immune Responses in Atherosclerosis 198
10-Year Follow-Up of Patients With Everolimus-Eluting Versus Bare-Metal Stents After ST-Segment Elevation Myocardial Infarction 197
Fractional flow reserve evaluation and chronic kidney disease: Analysis from a multicenter Italian registry (the FREAK study) 196
The Use of Multimodality Imaging for the Diagnosis of Myocardial Outpouchings and Invaginations: A Systematic Review 195
Reduced rate of hospital admissions for ACS during Covid-19 outbreak in northern Italy 195
Factor XIIIA V34L and Factor XIIIB H95R Gene Polymorphisms: Effects on the Risk of Myocardial Infarction and on Survival. 194
Coronary Physiology Guidance vs. Conventional Angiography for Optimization of Percutaneous Coronary Intervention: the AQVA II Trial 193
Occurrence, causes, and outcome after switching from ticagrelor to clopidogrel in a real-life scenario: data from a prospective registry 193
A Patient-Level Pooled Analysis Assessing the Impact of the SYNTAX (Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery) Score on 1-Year Clinical Outcomes in 6,508 Patients Enrolled in Contemporary Coronary Stent Trials 193
Relationship between paraoxonase Q192R gene polymorphism and on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention 192
CHA2DS2-VASc risk factors as predictors of stroke after acute coronary syndrome: A systematic review and meta-analysis 192
Structural Abnormalities in Brugada Syndrome and Non-Invasive Cardiac Imaging: A Systematic Review 191
Two-year clinical follow-up after sirolimus-eluting versus bare-metal stent implantation assisted by systematic glycoprotein IIb/IIIa Inhibitor Infusion in patients with myocardial infarction: results from the STRATEGY study 191
Prospective evaluation of on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention: Relationship with gene polymorphisms and clinical outcome 190
Platelet aggregation values in patients with cardiovascular risk factors are reduced by verbascoside treatment. A randomized study 189
Coronary Microvascular Dysfunction: PET, CMR and CT Assessment 189
QFR-Based Virtual PCI or Conventional Angiography to Guide PCI: The AQVA Trial 188
Short-versus long-term duration of dual-antiplatelet therapy after coronary stenting: A randomized multicenter trial 188
Transcriptomic profiling of calcified aortic valves in clonal hematopoiesis of indeterminate potential carriers 187
Development, optimization and validation of an absolute specific assay for active myeloperoxidase (MPO) and its application in a clinical context: Role of MPO specific activity in coronary artery disease 187
Totale 28.133
Salva come PNG Salva come JPEG
Categoria #
all - tutte 333.041
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.134
Totale 335.175
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021252 0 0 0 0 0 0 0 0 0 0 0 252
2021/20223.161 274 287 207 148 146 163 193 195 142 239 337 830
2022/20232.784 340 126 141 235 406 396 177 251 360 71 191 90
2023/20242.794 169 292 130 91 214 490 132 281 68 128 142 657
2024/202512.666 313 330 920 586 1.425 1.211 806 708 2.320 1.302 1.514 1.231
2025/202639.113 2.969 1.574 3.299 3.858 4.751 2.088 3.630 1.945 7.207 3.898 2.448 1.446
Totale 73.855